Krupakar Parthasarathy

Employment

• Sathyabama Institute of Science and Technology Scientist E
  2015 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (31)

• Patient-derived organoids in gynaecological cancers: emerging tools for therapy and disease modelling
  Clinical and Translational Oncology 2026 DOI: 10.1007/s12094-026-04458-7
  +Save
• Molecular Characterization of SARS-CoV-2 N Protein Interfaces: Implications for Oligomerization, RNA Binding, and Phase Separation
  2026 DOI: 10.64898/2026.03.06.710084
  +Save
• Comparative Evaluation of Iron Oxide Nanoparticle-Induced Cytotoxicity and Total Cellular Protein Content in 2D and 3D Cell Culture Models
  BioNanoScience 2026 DOI: 10.1007/s12668-026-02781-5
  +Save
• Viral ecology in chiroptera: human-wildlife interactions and pandemic risk
  Veterinary Research Communications 2025 DOI: 10.1007/s11259-025-10850-5
  +Save
• Dengue virus: structure, genome, evolution and challenges to control and prevent transmission
  Antonie van Leeuwenhoek 2025 DOI: 10.1007/s10482-025-02153-1
  +Save
• Role of Natural Polymers in Hydrogel-Based Scaffolds for Tissue Engineering Applications
  Regenerative Engineering and Translational Medicine 2025 DOI: 10.1007/s40883-025-00462-5
  +Save
• New frontiers in anti-cancer drug testing: The need for a relevant In vitro testing model
  NAM Journal 2025 DOI: 10.1016/j.namjnl.2024.100003
  +Save
• Lung Organoids: Systematic Review of Recent Advancements and its Future Perspectives
  Tissue Engineering and Regenerative Medicine 2024 DOI: 10.1007/s13770-024-00628-2
  +Save
• In vitro antibacterial activity of biosynthesized silver nanoparticles against gram negative bacteria
  Inorganic and Nano-Metal Chemistry 2024 DOI: 10.1080/24701556.2022.2034014
  +Save
• In silico Docking Analysis of the FDA-Approved Drugs on Envelope Protein of SARS CoV-2 Omicron Variant
  Biomedical and Pharmacology Journal 2023 DOI: 10.13005//bpj/2775
  +Save